Skip to main content
Back to Draper Associates

Draper Associates's Biotechnology Portfolio

Browse 12 Biotechnology companies funded by Draper Associates. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
12
Total Funding in Biotechnology
$229.9M

Biotechnology Portfolio Companies (12)

Export
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPharmaceutical

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

San Francisco, United States
March 2026
$19.8M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeuroscienceRobotics

Phantom Neuro develops muscle-machine interfaces for robotic limb rehabilitation solutions.

Austin, United States
April 2025
$19.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyInfrastructure

AI research assistant for biology.

Issaquah, United States
April 2025
$4.5M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.

Durham, United States
December 2024
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPharmaceutical

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

San Francisco, United States
January 2024
$45.0M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningMedicalVeterinary

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Mountain View, United States
November 2023
$23.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsLife Science

Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.

Austin, United States
February 2026
$60.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedical

Muse Bio is a biotechnology research centre that transforms menstrual blood into renewable mesenchymal stem cells.

San Francisco, United States
January 2026
$1.1M
Pre-Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalProduct Research

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

Chicago, United States
December 2025
$856K
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalMedical Device

Lyric Bio develops 3D tissue-enabled bioreactors to scale donor-sourced therapeutics, starting with intravenous immunoglobulin.

Palo Alto, United States
December 2025
$6.6M
Seed

Founder Contacts

19,000+ verified contacts

Biotechnology

Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).

Cambridge, United States
November 2025
$5.0M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth Care

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

South San Francisco, United States
October 2025
$45.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

Explore Draper Associates's Full Portfolio

View all companies funded by Draper Associates across every industry and funding stage.

View Full Draper Associates Portfolio
Draper Associates Biotechnology Portfolio - 12 Companies | VCBacked